Sandoz Group AG (SWX:SDZ)
83.74
+0.36 (0.43%)
Nov 11, 2026, 12:44 PM CET
Sandoz Group AG Revenue
Sandoz Group AG had revenue of $5.78B USD in the half year ending June 30, 2026, with 14.26% growth. This brings the company's total for the last twelve months to $11.68B, up 10.29% year-over-year. In the year 2025, Sandoz Group AG had annual revenue of $11.16B with 7.44% growth. That makes Sandoz Group AG the 1,318th largest company in the world by revenue and 23rd in Switzerland.
Revenue (ttm)
$11.68B
Revenue Growth
+10.29%
P/S Ratio
3.84
Revenue / Employee
$583.80K
Employees
20,000
Market Cap
36.23B CHF
Revenue by Segment
Fiscal year ended Dec 31, 2025 See the full Sandoz Group AG breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 11.16B | 773.00M | 7.44% |
| Dec 31, 2024 | 10.38B | 405.00M | 4.06% |
| Dec 31, 2023 | 9.98B | 673.00M | 7.23% |
| Dec 31, 2022 | 9.31B | -372.00M | -3.84% |
| Dec 31, 2021 | 9.68B | 20.00M | 0.21% |
| Dec 31, 2020 | 9.66B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Roche Holding AG | 62.96B |
| Novartis AG | 47.86B |
| Alcon | 8.78B |
| Lonza Group AG | 6.87B |
| Galderma Group AG | 4.79B |
| Galenica AG | 4.29B |
| Sonova Holding AG | 3.61B |
| Straumann Holding AG | 2.64B |
Sandoz Group AG News
- 6 days ago - COLL or SDZNY: Which Is the Better Value Stock Right Now? - Nasdaq
- 14 days ago - Sandoz Shares Fall After Company Turns Cautious on Sales Guidance - WSJ
- 14 days ago - Sandoz Group AG Earnings Call Transcript: Q3 2026 - Transcripts
- 14 days ago - Sandoz Group AG Earnings release: Q3 2026 - Filings
- 14 days ago - Sandoz Group AG Slides: Q3 2026 - Filings
- 14 days ago - Generic drugmaker Sandoz lowers sales outlook, lifts profit forecast - Reuters
- 15 days ago - ‘Why do we value a Mars bar more than life-saving medicine?’ Sandoz CEO calls for level playing field with cheap Chinese antibiotics - Fortune
- 16 days ago - Sandoz Group AG - Depositary Receipt Consensus Price Target Raised 10.10% to $93.47 - Nasdaq